Research for a life without cancer
At the DKFZ, we want to ensure that fewer people develop cancer, that cancer can be cured or treated so effectively that those affected can live with the disease and grow old with a good quality of life.
About DKFZ
Latest from DKFZ
In ovarian cancer, immunotherapies using checkpoint inhibitors have so far been effective in only a small number of patients. Researchers at the Helmholtz Institute for Translational Oncology (HI-TRON Mainz*) have now discovered that lipid metabolism processes in the tumor microenvironment play a decisive role in how well such therapies work. The findings open up new avenues for using immunotherapies in a more targeted manner, increasing their effectiveness, and overcoming resistance.
Our research opens doors in the fight against cancer
Do you have questions on the topic of cancer?
Let us advise you!
Doctors from the Cancer Information Service answer your questions every day. Find out more now for free!
